The top 10 key targets of DHGC in the treatment of AKI were identified as ESR1, AR, PPARG, ESR2, GSK3β, PRSS1, NCOA2, SIRT3, PTGS1, and ACHE. The gene discussed is GSK3B; the disease is acute kidney injury.